Olatec Therapeutics

Manufacturing · New York, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

800 5th Ave Apt 25D, New York, New York,...

Revenue

<$5 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development

About Olatec Therapeutics

Olatec is a privately held biopharmaceutical company focused on the clinical development of NLRP3 antagonist therapeutics aimed at treating a wide range of inflammatory diseases, including arthritis, heart failure, and various cancers. Their lead compound, dapansutrile, has shown clinical benefits in reducing systemic inflammation and has a favorable safety profile. With a robust pipeline of approximately 40 pharmaceutical candidates and a strong intellectual property portfolio, Olatec is positioned to make significant advancements in inflammation treatment. The company operates in the United States and Europe, leveraging a team of experienced management and international thought leaders in inflammation and immunology.Explore more
Olatec Therapeutics's Social MediaSIC Code 28,283NAICS Code 32,325Show more

Olatec Therapeutics Org Chart

DS
United States flag for contact location.

Founder & Chief Executive Officer

Flame icon indicating likelihood to engage via phone.PhoneFlame icon indicating likelihood to engage via email.Email
TR
United States flag for contact location.

Managing Director

PhoneEmail
JR
United States flag for contact location.

Vice President, Finance & Treasurer

PhoneEmail
CB
United States flag for contact location.

Vice President, Compliance & Risk

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Compare Similar Companies to Olatec Therapeutics

Compare insights from companies similar to Olatec Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Olatec Therapeutics

<$5M
11-50
Private
$40M
2003
DS
Damaris SkourasFounder & CEO
<$5M
11-50
Private
-
2015
WM
Werner MeierChief Scientific Officer
1-10
Public
$19.8M
1965
Illustration of an envelope

Olatec Therapeutics Tech Stack

A closer look at the technologies used by Olatec Therapeutics

Top Manufacturing Companies

Frequently Asked Questions Regarding Olatec Therapeutics

What is Olatec Therapeutics's official website?
Olatec Therapeutics's official website is www.olatec.com
What is Olatec Therapeutics's Revenue?
Olatec Therapeutics's revenue is <$5 Million
What is Olatec Therapeutics's SIC code?
Olatec Therapeutics's SIC: 28,283
What is Olatec Therapeutics's NAICS code?
Olatec Therapeutics's NAICS: 32,325
How many employees does Olatec Therapeutics have?
Olatec Therapeutics has 11-50 employees
What industry does Olatec Therapeutics belong to?
Olatec Therapeutics is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Olatec Therapeutics competition?
Olatec Therapeutics top competitors include: Revitope Oncology, GT Biopharma
What technology does Olatec Therapeutics use?
Some of the popular technologies that Olatec Therapeutics uses are: reCAPTCHA, Microsoft 365, GoDaddy DNS, DigiCert
What does Olatec Therapeutics do?

Olatec is a privately held biopharmaceutical company focused on the clinical development of NLRP3 antagonist therapeutics aimed at treating a wide range of inflammatory diseases, including arthritis, heart failure, and various cancers. Their lead compound, dapansutrile, has shown clinical benefits in reducing systemic inflammation and has a favorab... le safety profile. With a robust pipeline of approximately 40 pharmaceutical candidates and a strong intellectual property portfolio, Olatec is positioned to make significant advancements in inflammation treatment. The company operates in the United States and Europe, leveraging a team of experienced management and international thought leaders in inflammation and immunology.Read More

What are Olatec Therapeutics social media links?
Olatec Therapeutics Linkedin page Olatec Therapeutics Twitter page
Who invested in Olatec Therapeutics?
Olatec Therapeutics has 2 investors including Sanders Morris Harris and Advection Growth Capital.
Is Olatec Therapeutics a public company?
Olatec Therapeutics is private company therefore does not currently have an official ticker symbol
See more information about Olatec Therapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.